Clinical Trials on Resectable Soft Tissue Sarcoma

Total 4718 results

Ohio State University Comprehensive Cancer Center
Patient-Centered Outcomes Research Institute

Not yet recruiting

Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall

Resectable Soft Tissue Sarcoma | Resectable Undifferentiated Pleomorphic Sarcoma | Resectable Liposarcoma

United States
Centre Leon Berard

Recruiting

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma (SarQuantIRM)

Soft Tissue Sarcoma | Resectable Soft Tissue Sarcoma | Adult Soft Tissue Sarcoma

France
Institut Bergonié
Novartis; Chugai Pharma France

Recruiting

Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas (CIRSARC)

Resectable | Non-metastatic Soft-tissue Sarcoma

France
Mayo Clinic
National Cancer Institute (NCI)

Completed

An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

Soft Tissue Sarcoma | Recurrent Soft Tissue Sarcoma | Resectable Soft Tissue Sarcoma

United States
University Health Network, Toronto

Not yet recruiting

BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas

Sarcoma | Sarcoma,Soft Tissue | Sarcomas | Sarcoma, Soft-tissue

Canada

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe